Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: Compulsory licensing

Access to medicines amendment of the WTO TRIPS Agreement. Hype or...

Ellen 't Hoen - April 11, 2017

12Page 2 of 2

Recent Posts

Strong call for transparency on medicine prices, cost of R&D at WHO Fair Pricing Forum
WHO Fair Pricing Forum: Watching for Drug Industry Accountability
Humiragate: AbbVie’s desperate attempts to keep its monopoly
Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in patent law.

Posts by Subject

Access to Medicines Cancer CDCA competition law Compulsory licensing compulsory licensing for export CRISPR Data exclusivity Delinkage dolutegravir European Commission European Union evergreening France Gilead Hepatitis C HIV IFPMA India innovation Italy LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands Orphan Drugs Patent Patents PrEP R&D rare diseases Scotland Sofosbuvir Spain SPC Supplementary Protection Certificates The Netherlands TRIPS flexibilities Truvada United Kingdom United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok